High burden on tuberculosis treatment for society-a survey study

3.8 million died with tuberculosis infections at an accelerated rate since 2018 and the trend will continue to reach 4.6 million by 2030 (Table 1) (Figure 1). Since 2018 the number of resistances has increased significantly, and the trend will continue until 2030, thus complicating treatment and increasing the costs from US dollars 8.2 billion in 2018 to dollars 32 billion in 2030 (Table 2) (Figure 2). The costs associated with resistant tuberculosis management with direct and indirect costs have been increasing ever since 2023 (Table 2) (Figure 2). The Heal Africa research team has demonstrated on 155 patients that a solution to cure the non-resistant cases and resistant cases exists thus reducing the costs and eradicating tuberculosis worldwide (Table 3) (Figure 3). The Heal Africa research team is seeking to expand the cohort study to 1000 patients to prove beyond doubt that this solution is unbiased. A projection chart to demonstrate the reduction of the death toll (from 4.05 million in 2024 to 0 in 2025) and the gains in terms of costs (from 18.8 US billion in 2024 to 1.8 US billion in 2025) by using our solution is given below (Table 3, Figure 3) & (Table 4, Figure 4).

Authors

Publication Details

Journal
Pharmacy & Pharmacology International Journal
Published
2024-09-30
DOI
https://doi.org/10.15406/ppij.2024.12.00449
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High burden on tuberculosis treatment for society-a survey study

Pascal Gisenya, Serge Kahatwa, Justin Lussy Paluku
Pharmacy & Pharmacology International Journal
Tuberculosis Research and Epidemiology
article

High burden on tuberculosis treatment for society-a survey study

Pascal Gisenya, Serge Kahatwa, Justin Lussy Paluku
article en

Abstract

3.8 million died with tuberculosis infections at an accelerated rate since 2018 and the trend will continue to reach 4.6 million by 2030 (Table 1) (Figure 1). Since 2018 the number of resistances has increased significantly, and the trend will continue until 2030, thus complicating treatment and increasing the costs from US dollars 8.2 billion in 2018 to dollars 32 billion in 2030 (Table 2) (Figure 2). The costs associated with resistant tuberculosis management with direct and indirect costs have been increasing ever since 2023 (Table 2) (Figure 2). The Heal Africa research team has demonstrated on 155 patients that a solution to cure the non-resistant cases and resistant cases exists thus reducing the costs and eradicating tuberculosis worldwide (Table 3) (Figure 3). The Heal Africa research team is seeking to expand the cohort study to 1000 patients to prove beyond doubt that this solution is unbiased. A projection chart to demonstrate the reduction of the death toll (from 4.05 million in 2024 to 0 in 2025) and the gains in terms of costs (from 18.8 US billion in 2024 to 1.8 US billion in 2025) by using our solution is given below (Table 3, Figure 3) & (Table 4, Figure 4).

Pharmacy & Pharmacology International JournalVol. 12(5)
Good health and well-being
Openalex Percentile: Top 77%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.